Compare CTSO & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTSO | BIOX |
|---|---|---|
| Founded | 1997 | 2001 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.9M | 23.7M |
| IPO Year | 2008 | 2019 |
| Metric | CTSO | BIOX |
|---|---|---|
| Price | $3.59 | $0.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.9K | ★ 248.4K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,503,908.00 | N/A |
| Revenue This Year | $4.91 | $59.25 |
| Revenue Next Year | $13.58 | $34.94 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 48.53 | N/A |
| 52 Week Low | $0.30 | $0.30 |
| 52 Week High | $7.44 | $2.19 |
| Indicator | CTSO | BIOX |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 33.50 |
| Support Level | $2.89 | $0.32 |
| Resistance Level | $4.22 | $0.40 |
| Average True Range (ATR) | 0.46 | 0.03 |
| MACD | -0.22 | -0.00 |
| Stochastic Oscillator | 9.19 | 12.69 |
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.